Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
Leukemia|June 3, 2024
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203Michelle Y Zhang, Megan Othus, Kerry McMillen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Pretargeted radioimmunotherapy for B-cell lymphomasDamian J Green, John M Pagel, Anastasia Pantelias, et al.
The Permanente Journal|July 10, 2026
Consultative General Internal Medicine for Complex Care: The Model, Outcomes, and Lessons LearnedAditya Kumar Ghosh, Joshua D Overgaard, Ibrahim Abubeker, et al.
Leukemia & Lymphoma|December 10, 2020
No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisibJacqueline C Barrientos, Peter Hillmen, Gilles Salles, et al.
Leukemia & Lymphoma|May 10, 2007
Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell linesShao Xu Ying, Sudeshna Seal, Nissa Abbassi, et al.
Leukemia & Lymphoma|July 3, 2015
Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remissionMazyar Shadman, Ajay K Gopal, Britt Kammerer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate modelEneida R Nemecek, Donald K Hamlin, Darrell R Fisher, et al.
Nuclear Medicine Communications|July 31, 2014
90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistributionManuela Matesan, Joseph Rajendran, Oliver W Press, et al.
Haematologica|November 30, 2023
Pirtobrutinib <i>versus</i> venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparisonOthman Al-Sawaf, Min-Hua Jen, Lisa M Hess, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2010
NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignanciesEdwin P Alyea, Daniel J DeAngelo, Jeffrey Moldrem, et al.
Pageof 22